Xtant Medical Holdings, Inc.

1.27 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Xtant Medical Holdings, Inc. stock is up 29.59% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 85.71% of the previous 13 February’s closed higher than January.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and osteoinductive potential of human bone.